A detailed history of Uni Super Management Pty LTD transactions in Moderna, Inc. stock. As of the latest transaction made, Uni Super Management Pty LTD holds 76,179 shares of MRNA stock, worth $1.89 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
76,179
Previous 60,849 25.19%
Holding current value
$1.89 Million
Previous $1.68 Million 17.22%
% of portfolio
0.01%
Previous 0.01%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 31, 2025

BUY
$23.51 - $34.67 $360,408 - $531,491
15,330 Added 25.19%
76,179 $1.97 Million
Q2 2025

Jul 22, 2025

BUY
$23.65 - $28.54 $118,084 - $142,500
4,993 Added 8.94%
60,849 $1.68 Million
Q1 2025

May 14, 2025

BUY
$28.35 - $47.53 $139,000 - $233,039
4,903 Added 9.62%
55,856 $1.58 Million
Q4 2024

Feb 11, 2025

BUY
$36.85 - $63.93 $768,764 - $1.33 Million
20,862 Added 69.33%
50,953 $2.12 Million
Q3 2024

Nov 13, 2024

BUY
$63.64 - $125.14 $657,273 - $1.29 Million
10,328 Added 52.26%
30,091 $2.01 Million
Q2 2024

Aug 05, 2024

BUY
$101.21 - $166.61 $668,492 - $1.1 Million
6,605 Added 50.2%
19,763 $2.35 Million
Q1 2024

May 13, 2024

BUY
$85.37 - $115.44 $847,809 - $1.15 Million
9,931 Added 307.75%
13,158 $1.4 Billion
Q4 2023

Feb 12, 2024

SELL
$69.51 - $104.43 $122,476 - $184,005
-1,762 Reduced 35.32%
3,227 $321 Million
Q3 2023

Nov 13, 2023

SELL
$96.41 - $126.61 $53,603 - $70,395
-556 Reduced 10.03%
4,989 $515 Million
Q2 2023

Nov 13, 2023

SELL
$118.5 - $160.53 $3.27 Million - $4.42 Million
-27,553 Reduced 83.25%
5,545 $674 Million
Q2 2023

Aug 14, 2023

BUY
$118.5 - $160.53 $3.92 Million - $5.31 Million
33,098 New
33,098 $4.02 Billion

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $9.69B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Uni Super Management Pty LTD Portfolio

Follow Uni Super Management Pty LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Uni Super Management Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Uni Super Management Pty LTD with notifications on news.